Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#41
JOURNAL ARTICLE
Uri Landes, Ilan Richter, Haim Danenberg, Ran Kornowski, Janarthanan Sathananthan, Ole De Backer, Lars Søndergaard, Mohamed Abdel-Wahab, Sung-Han Yoon, Raj R Makkar, Holger Thiele, Won-Keun Kim, Christian Hamm, Nicola Buzzatti, Matteo Montorfano, Sebastian Ludwig, Niklas Schofer, Lisa Voigtlaender, Mayra Guerrero, Abdallah El Sabbagh, Josep Rodés-Cabau, Jules Mesnier, Taishi Okuno, Thomas Pilgrim, Claudia Fiorina, Antonio Colombo, Antonio Mangieri, Helene Eltchaninoff, Luis Nombela-Franco, Maarten P H Van Wiechen, Nicolas M Van Mieghem, Didier Tchétché, Wolfgang H Schoels, Matthias Kullmer, Marco Barbanti, Corrado Tamburino, Jan-Malte Sinning, Baravan Al-Kassou, Gidon Y Perlman, Alfonso Ielasi, Chiara Fraccaro, Giuseppe Tarantini, Federico De Marco, Guy Witberg, Simon R Redwood, John C Lisko, Vasilis C Babaliaros, Mika Laine, Roberto Nerla, Ariel Finkelstein, Amnon Eitan, Ronen Jaffe, Philipp Ruile, Franz J Neumann, Nicolo Piazza, Horst Sievert, Kolja Sievert, Marco Russo, Martin Andreas, Matjaz Bunc, Azeem Latib, Sharon Bruoha, Rebecca Godfrey, David Hildick-Smith, Israel Barbash, Amit Segev, Pál Maurovich-Horvat, Balint Szilveszter, Konstantinos Spargias, Dionisis Aravadinos, Tamim M Nazif, Martin B Leon, John G Webb
BACKGROUND: As transcatheter aortic valve (TAV) replacement is increasingly used in patients with longer life expectancy, a sizable proportion will require redo TAV replacement (TAVR). The unique configuration of balloon-expandable TAV (bTAV) vs a self-expanding TAV (sTAV) potentially affects TAV-in-TAV outcome. OBJECTIVES: The purpose of this study was to better inform prosthesis selection, TAV-in-TAV outcomes were assessed according to the type of initial and subsequent TAV...
August 8, 2022: JACC. Cardiovascular Interventions
#42
REVIEW
Tian-Yuan Xiong, Walid Ben Ali, Yuan Feng, Kentaro Hayashida, Hasan Jilaihawi, Azeem Latib, Michael Kang-Yin Lee, Martin B Leon, Raj R Makkar, Thomas Modine, Christoph Naber, Yong Peng, Nicolo Piazza, Michael J Reardon, Simon Redwood, Ashok Seth, Lars Sondergaard, Edgar Tay, Didier Tchetche, Wei-Hsian Yin, Mao Chen, Bernard Prendergast, Darren Mylotte
Indications for transcatheter aortic valve implantation (TAVI) have expanded in many countries to include patients with aortic stenosis who are at low surgical risk, and a similar expansion to this cohort is anticipated elsewhere in the world, together with an increase in the proportion of patients with bicuspid aortic valve (BAV) morphology as the age of the patients being treated decreases. To date, patients with BAV have been excluded from major randomized trials of TAVI owing to anatomical considerations...
January 2023: Nature Reviews. Cardiology
#43
MULTICENTER STUDY
Carmelo Lucio Sturiale, Alba Scerrati, Luca Ricciardi, Oriela Rustemi, Anna Maria Auricchio, Nicolò Norri, Amedeo Piazza, Fabio Ranieri, Alberto Tomatis, Alessio Albanese, Vincenzo Di Egidio, Marco Farneti, Annunziato Mangiola, Enrico Marchese, Antonino Raco, Lorenzo Volpin, Gianluca Trevisi
Endovascular treatment has emerged as the predominant approach in intracranial aneurysms. However, surgical clipping is still considered the best treatment for middle cerebral artery (MCA) aneurysms in referral centers. Here we compared short- and long-term clinical and neuroradiological outcomes in patients with MCA aneurysms undergoing clipping or coiling in 5 Italian referral centers for cerebrovascular surgery. We retrospectively reviewed 411 consecutive patients admitted between 2015 and 2019 for ruptured and unruptured MCA aneurysm...
October 2022: Neurosurgical Review
#44
JOURNAL ARTICLE
Nicolo Piazza, Ruediger Lange, Patrick Serruys
No abstract text is available yet for this article.
April 26, 2022: Archives of Cardiovascular Diseases
#45
EDITORIAL
Nicolo Piazza, Giuseppe Martucci, Marco Spaziano
No abstract text is available yet for this article.
January 24, 2022: JACC. Cardiovascular Interventions
#46
JOURNAL ARTICLE
Luiz F Ybarra, Nicolo Piazza
No abstract text is available yet for this article.
January 4, 2022: Circulation
#47
JOURNAL ARTICLE
Maria Rosaria Valerio, Pietro Spadaro, Concetta Arcanà, Nicolò Borsellino, Calogero Cipolla, Paolo Vigneri, Dario Piazza, Vittorio Gebbia
A retrospective analysis of 70 patients with triple-negative or hormone-resistant advanced breast carcinoma who had not previously received chemotherapy was carried out. Patients received oral vinorelbine 60 mg/m2 on day 1 and 8, plus capecitabine 1000 mg/m2 bid for 14 consecutive days every 3 weeks. Overall response rate was 53% with a 9% complete response rate. Stable disease was recorded in 27% of the cases. Median progression-free survival was 7.9 months and median overall survival was 29.2 months...
December 2021: Future Science OA
#48
REVIEW
Diagnostic Work-Up of the Aortic Patient: An Integrated Approach toward the Best Therapeutic Option.
Michele Pighi, Davide Giovannini, Roberto Scarsini, Nicolo Piazza
Aortic stenosis (AS) is the most common valvular heart disease. In the last decade, transcatheter aortic valve implantation (TAVI) has become the standard of care for symptomatic patients at high surgical risk. Recently, indications to TAVI have also been extended to the low surgical risk and intermediate surgical risk populations. Consequently, in this setting, some aspects acquire greater relevance: surgical risk evaluation, clinical assessment, multimodality imaging of the valve, and management of coronary artery disease...
October 31, 2021: Journal of Clinical Medicine
#49
JOURNAL ARTICLE
Rosie Fountotos, Haroon Munir, Michael Goldfarb, Sandra Lauck, Dae Kim, Louis Perrault, Rakesh Arora, Emmanuel Moss, Lawrence G Rudski, Melissa Bendayan, Palina Piankova, Victoria Hayman, Julia Rodighiero, Marie-Claude Ouimet, Sarah Lantagne, Nicolo Piazza, Jonathan Afilalo
BACKGROUND: While multi-dimensional frailty scales have been proven to predict mortality and morbidity in cardiac surgery, there is need for rapid tools that could be easily administered at point-of-care. Handgrip strength (HGS) is an attractive option which can be measured in acutely ill and bedbound patients, although it has yet to be validated in a large cardiac surgery cohort. METHODS: This is a post-hoc analysis of a multicenter prospective study in older patients undergoing coronary artery bypass grafting (CABG) and/or valve surgery between 2011 and 2019...
August 28, 2021: Canadian Journal of Cardiology
#50
JOURNAL ARTICLE
Moyang Wang, Guangyuan Song, Mao Chen, Yuan Feng, Jian'an Wang, Xianbao Liu, Shenghua Zhou, Zhenfei Fang, Yaling Han, Kai Xu, Bo Yu, Bo Xu, Yuejin Yang, Nicolo Piazza, Yongjian Wu, Run-Lin Gao
BACKGROUND: In the last decade, transcatheter aortic valve implantation (TAVI) has developed rapidly in China. As TAVI progresses towards low surgical risk patients, the total number of TAVI procedures will grow exponentially. There is a need to develop a domestic TAVI device designed for Chinese patients. AIMS: The aim of this study was to evaluate the safety and efficacy of a self-expanding valve (TaurusOne transcatheter aortic valve system) in the treatment of patients with symptomatic severe aortic stenosis in China...
January 28, 2022: EuroIntervention
#51
JOURNAL ARTICLE
Troels Højsgaard Jørgensen, Nicolaj Hansson, Ole De Backer, Gintautas Bieliauskas, Christian Juhl Terkelsen, Xi Wang, Jesper Møller Jensen, Evald Høj Christiansen, Nicolo Piazza, Jesper Hastrup Svendsen, Bjarne Linde Nørgaard, Lars Søndergaard
BACKGROUND: There is limited data on the association of membranous septum (MS) morphology and transcatheter heart valve (THV) implantation depth, and the development of new conduction abnormalities after transcatheter aortic valve replacement (TAVI). AIMS: To describe the morphology of the MS and predict the risk of new CA after TAVI based on the MS morphology and THV implantation depth. METHODS: Based on pre-procedural CT-scans the MS depth was measured for every 25% of the entire MS width in 272 TAVI-patients without pre-procedural bundle branch block (BBB) or pacemaker...
August 3, 2021: EuroIntervention
#52
JOURNAL ARTICLE
Joshua Solomon, Emmanuel Moss, Jean-Francois Morin, Yves Langlois, Renzo Cecere, Benoit de Varennes, Kevin Lachapelle, Nicolo Piazza, Giuseppe Martucci, Melissa Bendayan, Palina Piankova, Victoria Hayman, Marie-Claude Ouimet, Lawrence G Rudski, Jonathan Afilalo
Background The Essential Frailty Toolset (EFT) was shown to be easy to use and predictive of adverse events in patients undergoing aortic valve replacement procedures. The objective of this study was to evaluate the EFT in patients undergoing coronary artery bypass grafting procedures. Methods and Results The McGill Frailty Registry prospectively included patients ≥60 years of age undergoing urgent or elective isolated coronary artery bypass grafting between 2011 and 2018 at 2 hospitals. The preoperative EFT was scored 0 to 5 points as a function of timed chair rises, Mini-Mental Status Examination, serum albumin, and hemoglobin...
July 28, 2021: Journal of the American Heart Association
#53
JOURNAL ARTICLE
Wojciech Wojakowski, Grzegorz Smolka, Nicolo Piazza, Radosław Gocoł, Damian Hudziak, Marek Jędrzejek, Piotr Pysz
No abstract text is available yet for this article.
April 16, 2021: Kardiologia Polska
#54
Philippe Généreux, Nicolo Piazza, Maria C Alu, Tamim Nazif, Rebecca T Hahn, Philippe Pibarot, Jeroen J Bax, Jonathon A Leipsic, Philipp Blanke, Eugene H Blackstone, Matthew T Finn, Samir Kapadia, Axel Linke, Michael J Mack, Raj Makkar, Roxana Mehran, Jeffrey J Popma, Michael Reardon, Josep Rodes-Cabau, Nicolas M Van Mieghem, John G Webb, David J Cohen, Martin B Leon
AIMS: The Valve Academic Research Consortium (VARC), founded in 2010, was intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these endpoints for transcatheter and surgical aortic valve clinical trials. Rapid evolution of the field, including the emergence of new complications, expanding clinical indications, and novel therapy strategies have mandated further refinement and expansion of these definitions to ensure clinical relevance. This document provides an update of the most appropriate clinical endpoint definitions to be used in the conduct of transcatheter and surgical aortic valve clinical research...
June 1, 2021: Journal of the American College of Cardiology
#55
JOURNAL ARTICLE
Philippe Généreux, Nicolo Piazza, Maria C Alu, Tamim Nazif, Rebecca T Hahn, Philippe Pibarot, Jeroen J Bax, Jonathon A Leipsic, Philipp Blanke, Eugene H Blackstone, Matthew T Finn, Samir Kapadia, Axel Linke, Michael J Mack, Raj Makkar, Roxana Mehran, Jeffrey J Popma, Michael Reardon, Josep Rodes-Cabau, Nicolas M Van Mieghem, John G Webb, David J Cohen, Martin B Leon
AIMS: The Valve Academic Research Consortium (VARC), founded in 2010, was intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these endpoints for transcatheter and surgical aortic valve clinical trials. Rapid evolution of the field, including the emergence of new complications, expanding clinical indications, and novel therapy strategies have mandated further refinement and expansion of these definitions to ensure clinical relevance. This document provides an update of the most appropriate clinical endpoint definitions to be used in the conduct of transcatheter and surgical aortic valve clinical research...
May 14, 2021: European Heart Journal
#56
JOURNAL ARTICLE
Zouhair Rahhab, David Scott Lim, Stephen H Little, Maurizio Taramasso, Shingo Kuwata, Matteo Saccocci, Corrado Tamburino, Carmelo Grasso, Christian Frerker, Theresa Wißt, Ross Garberich, Jörg Hausleiter, Daniel Braun, Eleonora Avenatti, Victoria Delgado, Gian Paolo Ussia, Fausto Castriota, Roberto Nerla, Hüseyin Ince, Alper Öner, Rodrigo Estevez-Loureiro, Azeem Latib, Damiano Regazzoli, Nicolo Piazza, Hind Alosaimi, Peter P T de Jaegere, Jeroen Bax, Danny Dvir, Francesco Maisano, Paul Sorajja, Michael J Reardon, Nicolas M Van Mieghem
Background Recurrence of mitral regurgitation (MR) after surgical mitral valve repair (SMVR) varies and may require reoperation. Redo mitral valve surgery can be technically challenging and is associated with increased risk of mortality and morbidity. We aimed to assess the feasibility and safety of MitraClip as a treatment strategy after failed SMVR and identify procedure modifications to overcome technical challenges. Methods and Results This international multicenter observational retrospective study collected information for all patients from 16 high-volume hospitals who were treated with MitraClip after failed SMVR from October 29, 2009, until August 1, 2017...
April 2, 2021: Journal of the American Heart Association
#57
EDITORIAL
Marco Spaziano, Jeremy Y Levett, Nicolo Piazza
No abstract text is available yet for this article.
January 25, 2021: JACC. Cardiovascular Interventions
#58
JOURNAL ARTICLE
Jeremy Ben-Shoshan, Hind Alosaimi, Pascal Thériault Lauzier, Michele Pighi, Yeela Talmor-Barkan, Pavel Overtchouk, Giuseppe Martucci, Marco Spaziano, Ariel Finkelstein, Hemal Gada, Nicolo Piazza
OBJECTIVES: The purpose of this study was to assess the concordance between transcatheter aortic valve implantation angles generated by the "double S-curve" and "cusp-overlap" techniques. BACKGROUND: The "double S-curve" and "cusp-overlap" methods aim to define optimal fluoroscopic projections for transcatheter aortic valve replacement (TAVR) with a self-expandable device. METHODS: The study included 100 consecutive patients undergoing TAVR with self-expanding device planned by multidetector computed tomography...
January 25, 2021: JACC. Cardiovascular Interventions
#59
COMPARATIVE STUDY
Uri Landes, Janarthanan Sathananthan, Guy Witberg, Ole De Backer, Lars Sondergaard, Mohamed Abdel-Wahab, David Holzhey, Won-Keun Kim, Christian Hamm, Nicola Buzzatti, Matteo Montorfano, Sebastian Ludwig, Lenard Conradi, Moritz Seiffert, Mayra Guerrero, Abdallah El Sabbagh, Josep Rodés-Cabau, Leonardo Guimaraes, Pablo Codner, Taishi Okuno, Thomas Pilgrim, Claudia Fiorina, Antonio Colombo, Antonio Mangieri, Helene Eltchaninoff, Luis Nombela-Franco, Maarten P H Van Wiechen, Nicolas M Van Mieghem, Didier Tchétché, Wolfgang H Schoels, Matthias Kullmer, Corrado Tamburino, Jan-Malte Sinning, Baravan Al-Kassou, Gidon Y Perlman, Haim Danenberg, Alfonso Ielasi, Chiara Fraccaro, Giuseppe Tarantini, Federico De Marco, Simon R Redwood, John C Lisko, Vasilis C Babaliaros, Mika Laine, Roberto Nerla, Fausto Castriota, Ariel Finkelstein, Itamar Loewenstein, Amnon Eitan, Ronen Jaffe, Philipp Ruile, Franz J Neumann, Nicolo Piazza, Hind Alosaimi, Horst Sievert, Kolja Sievert, Marco Russo, Martin Andreas, Matjaz Bunc, Azeem Latib, Rebecca Godfrey, David Hildick-Smith, Ming-Yu A Chuang, Philipp Blanke, Jonathon Leipsic, David A Wood, Tamim M Nazif, Susheel Kodali, Marco Barbanti, Ran Kornowski, Martin B Leon, John G Webb
BACKGROUND: Surgical aortic valve replacement and transcatheter aortic valve replacement (TAVR) are now both used to treat aortic stenosis in patients in whom life expectancy may exceed valve durability. The choice of initial bioprosthesis should therefore consider the relative safety and efficacy of potential subsequent interventions. OBJECTIVES: The aim of this study was to compare TAVR in failed transcatheter aortic valves (TAVs) versus surgical aortic valves (SAVs)...
January 5, 2021: Journal of the American College of Cardiology
#60
JOURNAL ARTICLE
Guy Witberg, Pablo Codner, Uri Landes, Marco Barbanti, Roberto Valvo, Ole De Backer, Joris F Ooms, Kolja Sievert, Abdallah El Sabbagh, Pilar Jimenez-Quevedo, Paul F Brennan, Alexander Sedaghat, Giulia Masiero, Paul Werner, Pavel Overtchouk, Yusuke Watanabe, Matteo Montorfano, Venu Reddy Bijjam, Manuel Hein, Claudia Fiorina, Dabit Arzamendi, Tania Rodriguez-Gabella, Felipe Fernández-Vázquez, Jose A Baz, Clemence Laperche, Carmelo Grasso, Luca Branca, Rodrigo Estévez-Loureiro, Tomás Benito-González, Ignacio J Amat Santos, Philipp Ruile, Darren Mylotte, Nicola Buzzatti, Nicolo Piazza, Martin Andreas, Giuseppe Tarantini, Jan-Malte Sinning, Mark S Spence, Luis Nombela-Franco, Mayra Guerrero, Horst Sievert, Lars Sondergaard, Nicolas M Van Mieghem, Didier Tchetche, John G Webb, Ran Kornowski
OBJECTIVES: The aim of this study was to describe baseline characteristics, and periprocedural and mid-term outcomes of patients undergoing transcatheter mitral valve interventions post-transcatheter aortic valve replacement (TAVR) and examine their clinical benefit. BACKGROUND: The optimal management of residual mitral regurgitation (MR) post-TAVR is challenging. METHODS: This was an international registry of 23 TAVR centers. RESULTS: In total, 106 of 24,178 patients (0...
December 14, 2020: JACC. Cardiovascular Interventions
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
